LONG BEACH, Calif.--(BUSINESS WIRE)--March 9, 2005--Obagi Medical Products’ Chairman and CEO, Austin McNamara, presented exciting business results and positive future at JP Morgan Pharmaceutical and Healthcare Conference in January. Obagi Medical Products is the leader in the direct-to-physician channel, its proprietary skin care systems are prescription-based and developed for the treatment and correction of skin disorders such as photodamage, hyperpigmentation, melasma and fine lines and wrinkles. Obagi Systems are dispensed in over 3,500 U.S. physician offices and around the globe in 34 countries. In the last 7 years, Obagi’s revenues have grown consistently at above +20% per year. Ageing Baby Boomers and the cultural trends to “look younger and healthier and better” are key drivers for this growth.
